pimagedine has been researched along with Alzheimer Disease in 10 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Singh, M | 1 |
Kaur, M | 1 |
Singh, N | 1 |
Silakari, O | 1 |
Díaz, A | 1 |
Rojas, K | 1 |
Espinosa, B | 1 |
Chávez, R | 1 |
Zenteno, E | 1 |
Limón, D | 1 |
Guevara, J | 1 |
Tóth, AE | 1 |
Tóth, A | 1 |
Walter, FR | 1 |
Kiss, L | 1 |
Veszelka, S | 1 |
Ózsvári, B | 1 |
Puskás, LG | 1 |
Heimesaat, MM | 1 |
Dohgu, S | 1 |
Kataoka, Y | 1 |
Rákhely, G | 1 |
Deli, MA | 1 |
Wei, Y | 1 |
Han, C | 1 |
Wang, Y | 1 |
Wu, B | 1 |
Su, T | 1 |
Liu, Y | 1 |
He, R | 1 |
Liu, H | 1 |
Chen, JP | 1 |
Zhang, WQ | 1 |
Carnevale, D | 1 |
Mascio, G | 1 |
D'Andrea, I | 1 |
Fardella, V | 1 |
Bell, RD | 1 |
Branchi, I | 1 |
Pallante, F | 1 |
Zlokovic, B | 1 |
Yan, SS | 1 |
Lembo, G | 1 |
Li, XH | 1 |
Xie, JZ | 1 |
Jiang, X | 1 |
Lv, BL | 1 |
Cheng, XS | 1 |
Du, LL | 1 |
Zhang, JY | 1 |
Wang, JZ | 1 |
Zhou, XW | 1 |
Münch, G | 1 |
Mayer, S | 1 |
Michaelis, J | 1 |
Hipkiss, AR | 1 |
Riederer, P | 1 |
Müller, R | 1 |
Neumann, A | 1 |
Schinzel, R | 1 |
Cunningham, AM | 1 |
Shapiro, HK | 1 |
Stanyer, L | 1 |
Betteridge, DJ | 1 |
Smith, CC | 1 |
1 review available for pimagedine and Alzheimer Disease
Article | Year |
---|---|
Carbonyl-trapping therapeutic strategies.
Topics: Aldehydes; Alzheimer Disease; Amines; Animals; Carbohydrate Metabolism; Fatty Acids; Guanidines; Hum | 1998 |
9 other studies available for pimagedine and Alzheimer Disease
Article | Year |
---|---|
Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer's disease: Design, synthesis and biological evaluations.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Chromans; Dose-Response | 2017 |
Aminoguanidine treatment ameliorates inflammatory responses and memory impairment induced by amyloid-beta 25-35 injection in rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Guanidines; Inflammation; Male; Memory Disorders; | 2014 |
Compounds blocking methylglyoxal-induced protein modification and brain endothelial injury.
Topics: Alzheimer Disease; Antioxidants; beta Catenin; Blood-Brain Barrier; Butadienes; Cell Line; Cell Surv | 2014 |
Ribosylation triggering Alzheimer's disease-like Tau hyperphosphorylation via activation of CaMKII.
Topics: Alzheimer Disease; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Survival; Diabe | 2015 |
[Inducible nitric oxide synthase induces beta-amyloid neurotoxicity in vivo].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Guanidines; Indazoles; Male; Maze Learning; Nitri | 2002 |
Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Alzheimer Disease; Amyloid beta-Peptides; An | 2012 |
Methylglyoxal induces tau hyperphosphorylation via promoting AGEs formation.
Topics: Alzheimer Disease; Animals; Cell Line, Tumor; Enzyme Activation; Glycation End Products, Advanced; G | 2012 |
Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzothiazoles; Carnosine; Cognition; Cross-Linking Reagen | 1997 |
An investigation into the mechanisms mediating plasma lipoprotein-potentiated beta-amyloid fibrillogenesis.
Topics: Aldehydes; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Apolipoproteins; Ascorbic Acid; B | 2002 |